Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-24 @ 9:11 PM
NCT ID:
NCT01414504
Eligibility Criteria:
Inclusion Criteria:
* PNG Infants aged 3 to 5 yrs of age who participated in previous PNG Neonatal PCV study and received PPV between 9 and 12 months of age, or age- and sex-matched controls who live in the same villages or urban area
* Informed parental/guardian consent
Exclusion Criteria:
* Known HIV infection or other immunosuppressive condition or treatment.
* Prior receipt of 2 doses of pneumococcal polysaccharide vaccine
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
5 Years
Study:
NCT01414504
Study Brief:
Protocol Section:
NCT01414504